CONBRIZA
Country: Ísrael
Tungumál: enska
Heimild: Ministry of Health
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
BAZEDOXIFENE AS ACETATE 20 MG
Fáanlegur frá:
NEOPHARM LTD
ATC númer:
G03XC02
Lyfjaform:
COATED TABLETS
Stjórnsýsluleið:
PER OS
Framleitt af:
PFIZER IRELAND PHARMACEUTICALS
Meðferðarhópur:
BAZEDOXIFENE
Ábendingar:
CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit
Leyfisdagur:
2013-04-01
